An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

• Status: Completed
• Trial end date: 2011-06-17
• Target enrollment: 0
• Participant gender: Female

Summary

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Previously treated for glabellar lines (hyperfunctional facial lines) with botulinum toxin Type A preparation

• Received 2 treatment cycles wtih botulinum toxin Type A (BOTOX®) prior to at least 1 treatment with botulinum toxin Type A (Xeomin®)

Exclusion Criteria:

• None